Neuroscience, Neurology, Neuromodulation, Mental Health, Parkinson Disease.
applied research towards new targets, biomarkers, and therapies since 2015, Johnson and Johnson’s approval of esketamine for depression and a loosening regulatory environment for psychedelic medicine has led to experiments with new care delivery models, and some big pharma companies have been